The global oligonucleotide therapy market reached around USD 8.6 billion in 2023 and is projected to soar to approximately USD 30.5 billion by 2031, reflecting a spectacular 15.8% CAGR during 2024–2031. Mid range forecasts project growth from USD 5.6 billion (2024) to nearly USD 9.8 billion (2029) a 12–14% CAGR highlighting a robust and multi‑year expansion trajectory.
Sample...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek